Review of Global Fund Window 1 funding requests reveals resurgence of malaria in Central and Eastern Africa, TRP says
The Technical Review Panel (TRP) says that based on its review of the funding requests in Window 1 of the current funding cycle, it believes there has been a resurgence of malaria in Central and Eastern Africa and that a change in approach is required.
The Regional Center for Technical Assistance (CRAT in its Spanish acronym) has developed a strategy to support civil society organizations (CSOs) and community groups in Latin America and the Caribbean (LAC) to plan for sustainability of their outreach strategies to control HIV, TB and malaria. CRAT is the host of the regional communication and coordination platform under the Global Fund’s Community, Rights and Gender (CRG) Initiative.
The payment of extra money to top up the salaries of workers implementing Global Fund grants was disallowed by the Fund two years ago, except in exceptional circumstances, but in some countries the organization is finding it hard to work out a way to keep the staff they need without paying these incentives.
According to four case studies recently published by the Eurasian Harm Reduction Network (EHRN), the readiness to transition harm reduction programs from Global Fund support to domestic funding in four countries in Eastern Europe and Central Asia ranges from 19% to 47%.
The four countries are Albania, Bosnia and Herzegovina, Macedonia, and Romania. See the table for further details.
Considerable work is being done in Eastern Europe and Central Asia (EECA) on transition planning. Discussions about transitioning from Global Fund financing started even before grants under the new funding model were approved for funding.
Currently there are several national CSOs in Moldova providing services to vulnerable and key populations and people living with HIV. These services include psychosocial support, prevention programming, and harm reduction. Funding for this work has come predominately from The Global Fund and has been administered by an NGO principal recipient, the Center for Health Policies and Studies.
Under the new co-financing requirements (previously called “counterpart financing requirements”) adopted by The Global Fund, countries no longer have to meet a minimum threshold expressed as a percentage of the cost of the national programs for HIV, TB, and malaria.
On 26-27 April 2016, the Global Fund Board held its 35th meeting in Abidjan, Côte d’Ivoire. GFO was present, with observer status.
The Global Fund’s new strategy for the period 2017-2022 has a strong focus on the sustainability of investments. This includes supporting countries that are transitioning from Global Fund support to domestic reliance for their disease programs.